The international association for the study of lung cancer lung cancer staging project: overview of challenges and opportunities in revising the nodal classification of …

RU Osarogiagbon, P Van Schil, DJ Giroux… - Journal of Thoracic …, 2023 - Elsevier
The status of lymph node involvement is a major component of the TNM staging system. The
N categories for lung cancer have remained unchanged since the fourth edition of the TNM …

Impact of examined lymph node count on precise staging and long-term survival of resected non–small-cell lung cancer: a population study of the US SEER database …

W Liang, J He, Y Shen, J Shen, Q He… - Journal of clinical …, 2017 - ascopubs.org
Purpose We investigated the correlation between the number of examined lymph nodes
(ELNs) and correct staging and long-term survival in non–small-cell lung cancer (NSCLC) …

Rationale for a minimum number of lymph nodes removed with non-small cell lung cancer resection: correlating the number of nodes removed with survival in 98,970 …

AX Samayoa, TA Pezzi, CM Pezzi, E Greer Gay… - Annals of surgical …, 2016 - Springer
Background The benefit of thoracic lymphadenectomy in the treatment of resectable non-
small cell lung cancer (NSCLC) continues to be debated. We hypothesized that the number …

A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis

Y Wang, Q Zhang, Z Gao, S Xin, Y Zhao, K Zhang… - Cancer cell …, 2019 - Springer
Background Lung adenocarcinoma (LUAD) patients experiencing lymph node metastasis
(LNM) always exhibit poor clinical outcomes. A biomarker or gene signature that could …

Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer

RU Osarogiagbon, X Yu - The Annals of Thoracic Surgery, 2013 - Elsevier
Background Nonexamination of lymph nodes is an extreme example of the variability of
pathologic nodal staging of non-small cell lung cancer. We compared the prevalence …

[HTML][HTML] Lymph node ratio may predict the benefit of postoperative radiotherapy in non–small-cell lung cancer

D Urban, J Bar, B Solomon, D Ball - Journal of Thoracic Oncology, 2013 - Elsevier
Introduction The use of postoperative radiotherapy (PORT) after resection of non–small-cell
lung cancer (NSCLC) is controversial, with some evidence suggesting a benefit in patients …

Analysis of lymph node sampling minimums in early stage non-small-cell lung cancer

AR Dezube, E Mazzola, CE Bravo-Iñiguez… - Seminars in Thoracic …, 2021 - Elsevier
Analyze “number of nodes” as an integer-valued variable to identify possible minimum
lymph node (LN) number to sample during lung cancer resection. The National Cancer …

Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: the number of involved nodal stations or the location-based pathological N …

L Xu, H Su, Y She, C Dai, M Zhao, J Gao, H Xie, Y Ren… - Chest, 2021 - Elsevier
Background The eighth edition of nodal classification for non-small cell lung cancer
(NSCLC) is defined only by the anatomical location of metastatic lymph nodes. Research …

Missed intrapulmonary lymph node metastasis and survival after resection of non-small cell lung cancer

MP Smeltzer, N Faris, X Yu, RA Ramirez… - The Annals of thoracic …, 2016 - Elsevier
Background Pathologic nodal stage is a key prognostic factor for patients with surgically
resected lung cancer. We previously described the extent of missed intrapulmonary nodal …

[HTML][HTML] TRIM44 promotes proliferation and metastasis in non-small cell lung cancer via mTOR signaling pathway

Y Xing, Q Meng, X Chen, Y Zhao, W Liu, J Hu, F Xue… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Tripartite motif-containing protein 44 (TRIM44) was recently identified as a potential
therapeutic target in several types of malignancy, but its effect on the clinical course of …